Bioengineer.org: Biomarker may aid in determining treatment for cancer patients
UC medical student leads research to aid treatment of glioblastoma
Patients with glioblastomas or malignant brain tumors, face a difficult future. The disease is fatal, and only about 5 percent of patients are alive five years after their diagnosis, explains Haidn Foster, a third-year medical student at the UC College of Medicine and first author of a recent study of glioblastoma patients in the scholarly journal Neuro-Oncology Advances.
The findings were reported by Bioengineer.org, a biotechnology news service.
Foster’s study looked at health outcomes of 188 glioblastoma patients and found that individuals who tested positive for an antibody indicating Human cytomegalovirus (HCMV) exposure lived an average of 404 days after their cancer diagnosis compared to an average of 530 days for patients who were never infected by HCMV.
A life expectancy difference of four months is an important consideration for patients and their physicians. “For glioblastoma patients time is precious and treatment that would prolong life by a few weeks or months is considered a victory,” said Foster.
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.
Celebrating the newest Bearcats on Decision Day
December 11, 2025
The University of Cincinnati admits its newest Bearcats for Fall 2026. Interest in the university is at an all-time high with more than 35,000 applicants for admission. Decision Day was also a time to celebrate 10 new Marian Spencer Scholarship recipients.